Your browser doesn't support javascript.
loading
A randomized-controlled trial of blonanserin and olanzapine as adjunct to antipsychotics in the treatment of patients with schizophrenia and dopamine supersensitivity psychosis: The ROADS study.
Niitsu, Tomihisa; Hata, Tatsuki; Nishimoto, Masahiko; Hosoda, Yutaka; Kimura, Atsushi; Oda, Yasunori; Suzuki, Masatoshi; Takase, Naoko; Seki, Ryota; Fujita, Kiyoshi; Endo, Mitsugu; Yoshida, Taisuke; Inoue, Masayuki; Hattori, Noriaki; Murakami, Tadashi; Imamura, Yukitsugu; Ogawa, Kohei; Fukami, Goro; Sato, Takatoshi; Kawasaki, Yohei; Hashimoto, Tasuku; Ishikawa, Masatomo; Shiina, Akihiro; Kanahara, Nobuhisa; Iyo, Masaomi.
Afiliación
  • Niitsu T; Department of Psychiatry, Chiba University Graduate School of Medicine, Chiba, Japan. Electronic address: niitsu@chiba-u.jp.
  • Hata T; Department of Psychiatry, Chiba University Graduate School of Medicine, Chiba, Japan; Fujita Hospital, Sosa, Chiba, Japan.
  • Nishimoto M; Soshu Hospital, Atsugi, Kanagawa, Japan.
  • Hosoda Y; Fujita Hospital, Sosa, Chiba, Japan; Child Psychiatry, Chiba University Hospital, Chiba, Japan.
  • Kimura A; Department of Psychiatry, Chiba University Graduate School of Medicine, Chiba, Japan.
  • Oda Y; Department of Psychiatry, Chiba University Graduate School of Medicine, Chiba, Japan.
  • Suzuki M; Mobara Mental Hospital, Mobara, Chiba, Japan.
  • Takase N; Mobara Mental Hospital, Mobara, Chiba, Japan.
  • Seki R; Department of Psychiatry, Chiba University Graduate School of Medicine, Chiba, Japan; Chiba Hospital, Funabashi, Chiba, Japan.
  • Fujita K; Okehazama Hospital Fujita Kokoro Care Center, Toyoake, Aichi, Japan.
  • Endo M; Asai Hospital, Togane, Chiba, Japan.
  • Yoshida T; Kisatazu Hospital, Kisarazu, Chiba, Japan.
  • Inoue M; Katsushikabashi Hospital, Tokyo, Japan.
  • Hattori N; Johmoh Hospital, Maebashi, Gunma, Japan.
  • Murakami T; Sanmaibashi Hospital, Ota, Gunma, Japan.
  • Imamura Y; Department of Neuropsychiatry, Asahi General Hospital, Asahi, Chiba, Japan.
  • Ogawa K; Yowa Hospital, Tokyo, Japan; Department of Neuropsychiatry, Nippon Medical School, Tokyo, Japan.
  • Fukami G; Chiba Psychiatric Medical Center, Chiba, Japan.
  • Sato T; Project Leader Office, Clinical Research Center, Chiba University Hospital, Chiba, Japan.
  • Kawasaki Y; Biostatistics Section, Clinical Research Center, Chiba University Hospital, Chiba, Japan.
  • Hashimoto T; Department of Psychiatry, Chiba University Graduate School of Medicine, Chiba, Japan; Sodegaura-Satsukidai Hospital, Sodegaura, Chiba, Japan.
  • Ishikawa M; Department of Psychiatry, Chiba University Graduate School of Medicine, Chiba, Japan.
  • Shiina A; Department of Psychiatry, Chiba University Graduate School of Medicine, Chiba, Japan; Division of Medical Treatment and Rehabilitation, Center for Forensic Mental Health, Chiba University, Chiba, Japan.
  • Kanahara N; Department of Psychiatry, Chiba University Graduate School of Medicine, Chiba, Japan; Division of Medical Treatment and Rehabilitation, Center for Forensic Mental Health, Chiba University, Chiba, Japan.
  • Iyo M; Department of Psychiatry, Chiba University Graduate School of Medicine, Chiba, Japan; Child Psychiatry, Chiba University Hospital, Chiba, Japan; Division of Medical Treatment and Rehabilitation, Center for Forensic Mental Health, Chiba University, Chiba, Japan.
Asian J Psychiatr ; 53: 102369, 2020 Oct.
Article en En | MEDLINE | ID: mdl-32920492
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trastornos Psicóticos / Esquizofrenia / Antipsicóticos Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Asian J Psychiatr Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trastornos Psicóticos / Esquizofrenia / Antipsicóticos Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Asian J Psychiatr Año: 2020 Tipo del documento: Article